27931000087102: Unadjuvanted vaccine product (qualifier value)

SNOMED CT Concept\valeur de l'attribut\Product characteristic (qualifier value)\Unadjuvanted vaccine product (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2020. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

141811000087117 Unadjuvanted vaccine product (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

141821000087113 Unadjuvanted vaccine product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Unadjuvanted vaccine product (qualifier value)	est un(e) (attribut)	Product characteristic (qualifier value)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus high dose each non-live antigen in parenteral dose form (medicinal product form)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
FLUZONE High-Dose 60 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf AGRIFLU SEQ	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf AFLURIA TETRA SEQ	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Agriflu 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
FLUZONE suspension for injection Sanofi Pasteur SA (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf INFLUVAC BGP	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf influenza A monovalent H1N1 unadjuvanted unspecified	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Inf FLUZONE High-Dose Quadrivalent SP	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage high dose each non-live antigen in parenteral dose form (medicinal product form)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some
Supemtek 45 micrograms per 0.5 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug)	Has product characteristic	True	Unadjuvanted vaccine product (qualifier value)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
141811000087117	Unadjuvanted vaccine product (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
141821000087113	Unadjuvanted vaccine product	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)